An Observational Study on Bevacizumab (Avastin) as First-Line Treatment in Colorectal Cancer Participants With Potentially Resectable Liver Metastases
Clinical trial NCT01343901 · COMPLETED
Trial details
- NCT number
- NCT01343901
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-09-30
- Primary completion
- 2015-06-30
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.